SCHEMBL1534498

SCHEMBL1534498

COc1cc(Br)ccc1C#CC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.50
NTSR1 P30989 1/20 0.50
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
ALDH1A1 P00352 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
KDM4E B2RXH2 2/20 0.40
MAPT P10636 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
POLB P06746 2/20 0.40
S1PR2 O95136 1/20 0.40
OPRK1 P41145 1/20 0.40
HTT P42858 1/20 0.40
VCP P55072 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1534733 0.89 HPGD (0.47) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL1534520 0.83 HPGD (0.50) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL1534448 0.83 CYP1A2 (0.50) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL1534376 0.83 HSP90AA1 (0.50) HSP90AA1NTSR1NPC1RAB9AALDH1A1
SCHEMBL1534428 0.82 HSP90AA1 (0.51) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL27167227 0.82 HSP90AA1 (0.63) HSP90AA1NTSR1NPC1RAB9AALDH1A1
SCHEMBL1534387 0.82 HSP90AA1 (0.48) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL1534333 0.80 HSP90AA1 (0.46) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL1534604 0.79 HSP90AA1 (0.48) HSP90AA1NTSR1CYP1A2CYP2D6HPGD
SCHEMBL1534418 0.79 HSP90AA1 (0.48) HSP90AA1NTSR1CYP1A2CYP2D6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR HSP90AA1 1265/4885NTSR1 4367/4885CYP1A2 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.